Skip to main content
Top
Published in: Neuroradiology 6/2013

01-06-2013 | Diagnostic Neuroradiology

3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson’s disease

Authors: Kimihiro Ogisu, Kohsuke Kudo, Makoto Sasaki, Ken Sakushima, Ichiro Yabe, Hidenao Sasaki, Satoshi Terae, Mitsuhiro Nakanishi, Hiroki Shirato

Published in: Neuroradiology | Issue 6/2013

Login to get access

Abstract

Introduction

Neuromelanin-sensitive MRI has been reported to be used in the diagnosis of Parkinson’s disease (PD), which results from loss of dopamine-producing cells in the substantia nigra pars compacta (SNc). In this study, we aimed to apply a 3D turbo field echo (TFE) sequence for neuromelanin-sensitive MRI and to evaluate the diagnostic performance of semi-automated method for measurement of SNc volume in patients with PD.

Methods

We examined 18 PD patients and 27 healthy volunteers (control subjects). A 3D TFE technique with off-resonance magnetization transfer pulse was used for neuromelanin-sensitive MRI on a 3T scanner. The SNc volume was semi-automatically measured using a region-growing technique at various thresholds (ranging from 1.66 to 2.48), with the signals measured relative to that for the superior cerebellar peduncle. Receiver operating characteristic (ROC) analysis was performed at all thresholds. Intra-rater reproducibility was evaluated by intraclass correlation coefficient (ICC).

Results

The average SNc volume in the PD group was significantly smaller than that in the control group at all the thresholds (P < 0.01, student t test). At higher thresholds (>2.0), the area under the curve of ROC (Az) increased (0.88). In addition, we observed balanced sensitivity and specificity (0.83 and 0.85, respectively). At lower thresholds, sensitivity tended to increase but specificity reduced in comparison with that at higher thresholds. ICC was larger than 0.9 when the threshold was over 1.86.

Conclusions

Our method can distinguish the PD group from the control group with high sensitivity and specificity, especially for early stage of PD.
Literature
1.
go back to reference Greenfield JG, Bosanquet FD (1953) The brain-stem lesions in Parkinsonism. J Neurol Neurosurg Psychiat 16:213–226CrossRefPubMed Greenfield JG, Bosanquet FD (1953) The brain-stem lesions in Parkinsonism. J Neurol Neurosurg Psychiat 16:213–226CrossRefPubMed
2.
go back to reference Fedorow H, Tribl F, Halliday G, Gerlach M, Riederer P, Double KL (2005) Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson’s disease. Prog Neurobiol 75:109–124CrossRefPubMed Fedorow H, Tribl F, Halliday G, Gerlach M, Riederer P, Double KL (2005) Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson’s disease. Prog Neurobiol 75:109–124CrossRefPubMed
3.
go back to reference Enochs WS, Petherick P, Bogdanova A, Mohr U, Weissleder R (1997) Paramagnetic metal scavenging by melanin: MR imaging. Radiology 204:417–423PubMed Enochs WS, Petherick P, Bogdanova A, Mohr U, Weissleder R (1997) Paramagnetic metal scavenging by melanin: MR imaging. Radiology 204:417–423PubMed
4.
go back to reference Hughes AJ, Daniel SE, Kilford L, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184CrossRefPubMed Hughes AJ, Daniel SE, Kilford L, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184CrossRefPubMed
5.
go back to reference Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiat 67:189–194CrossRefPubMed Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiat 67:189–194CrossRefPubMed
6.
go back to reference Sasaki M, Shibata E, Kudo K, Tohyama K (2008) Neuromelanin-sensitive MRI. Clin Neuroradiol 18:147–153CrossRef Sasaki M, Shibata E, Kudo K, Tohyama K (2008) Neuromelanin-sensitive MRI. Clin Neuroradiol 18:147–153CrossRef
7.
go back to reference Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, Takahashi S, Ehara S, Terayama Y, Sakai A (2006) Neuromelanin magnetic resonance imaging of lucus ceruleus and substantia nigra in Parkinson’s disease. Neuroreport 17:1215–1218CrossRefPubMed Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, Takahashi S, Ehara S, Terayama Y, Sakai A (2006) Neuromelanin magnetic resonance imaging of lucus ceruleus and substantia nigra in Parkinson’s disease. Neuroreport 17:1215–1218CrossRefPubMed
8.
go back to reference Shibata E, Sasaki M, Tohyama K, Otsuka K, Endoh J, Terayama Y, Sasaki A (2008) Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus. Biol Psychiatry 64:401–406CrossRefPubMed Shibata E, Sasaki M, Tohyama K, Otsuka K, Endoh J, Terayama Y, Sasaki A (2008) Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus. Biol Psychiatry 64:401–406CrossRefPubMed
9.
go back to reference Sasaki M, Inoue T, Tohyama K, Oikawa H, Ehara S, Ogawa A (2003) High-field MRI of the central nervous system: current approaches to clinical and microscopic imaging. Magn Reson Med Sci 2:133–139CrossRefPubMed Sasaki M, Inoue T, Tohyama K, Oikawa H, Ehara S, Ogawa A (2003) High-field MRI of the central nervous system: current approaches to clinical and microscopic imaging. Magn Reson Med Sci 2:133–139CrossRefPubMed
10.
go back to reference Truong TK, Chakeres DW, Beversdorf DQ, Scharre DW, Schmalbrock P (2006) Effects of static and rediofrequency magnetic field inhomogeneity in ultra-high field magnetic resonance imaging. Magn Reson Imaging 24:103–112CrossRefPubMed Truong TK, Chakeres DW, Beversdorf DQ, Scharre DW, Schmalbrock P (2006) Effects of static and rediofrequency magnetic field inhomogeneity in ultra-high field magnetic resonance imaging. Magn Reson Imaging 24:103–112CrossRefPubMed
11.
go back to reference Kudo K, Sasaki M, Yamada K, Momoshima S, Utsunomiya H, Shirato H, Ogasawara K (2010) Differences in CT perfusion maps generated by different commercial software: quantitative analysis by using identical source data of acute stroke patients. Radiology 254(1):200–209CrossRefPubMed Kudo K, Sasaki M, Yamada K, Momoshima S, Utsunomiya H, Shirato H, Ogasawara K (2010) Differences in CT perfusion maps generated by different commercial software: quantitative analysis by using identical source data of acute stroke patients. Radiology 254(1):200–209CrossRefPubMed
12.
go back to reference Nakane N, Nihashi T, Kawai H, Naganawa S (2008) Visualization of neuromelanin in the substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast. Magn Reson Med Sci 7(4):205–210CrossRefPubMed Nakane N, Nihashi T, Kawai H, Naganawa S (2008) Visualization of neuromelanin in the substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast. Magn Reson Med Sci 7(4):205–210CrossRefPubMed
13.
go back to reference Fearnley JM, Lees AJ (1991) Aging and Parkinson’s disease: substantia nigra regional selectivity. Brain 114(5):2283–2301CrossRefPubMed Fearnley JM, Lees AJ (1991) Aging and Parkinson’s disease: substantia nigra regional selectivity. Brain 114(5):2283–2301CrossRefPubMed
14.
go back to reference Kashihara K, Shinya T, Higaki F (2011) Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson’s disease. J Clin Neurosci 18:1093–1096CrossRefPubMed Kashihara K, Shinya T, Higaki F (2011) Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson’s disease. J Clin Neurosci 18:1093–1096CrossRefPubMed
15.
go back to reference Menke RA, Scholz J, Miller KL, Deoni S, Jbabdi S, Matthews PM, Zarei M (2009) MRI characteristics of the substantia nigra in Parkinson’s disease: a combined quantitative T1 and DTI study. NeuroImage 47(2):435–441CrossRefPubMed Menke RA, Scholz J, Miller KL, Deoni S, Jbabdi S, Matthews PM, Zarei M (2009) MRI characteristics of the substantia nigra in Parkinson’s disease: a combined quantitative T1 and DTI study. NeuroImage 47(2):435–441CrossRefPubMed
16.
go back to reference Wang JJ, Lin WY, Lu CS, Weng YH, Ng SH, Wang CH, Liu HL, Hsieh RH, Wan YL, Wai YY (2011) Parkinson disease: diagnostic utility of diffusion kurtosis imaging. Radiology 261(1):210–217CrossRefPubMed Wang JJ, Lin WY, Lu CS, Weng YH, Ng SH, Wang CH, Liu HL, Hsieh RH, Wan YL, Wai YY (2011) Parkinson disease: diagnostic utility of diffusion kurtosis imaging. Radiology 261(1):210–217CrossRefPubMed
17.
go back to reference Wallis LI, Paley MNJ, Graham JM, Grünewald RA, Wignall EL, Joy HM, Griffiths PD (2008) MRI assessment of basal ganglia iron deposition in Parkinson’s disease. J Magn Reson Imaging 28(5):1061–1067CrossRefPubMed Wallis LI, Paley MNJ, Graham JM, Grünewald RA, Wignall EL, Joy HM, Griffiths PD (2008) MRI assessment of basal ganglia iron deposition in Parkinson’s disease. J Magn Reson Imaging 28(5):1061–1067CrossRefPubMed
Metadata
Title
3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson’s disease
Authors
Kimihiro Ogisu
Kohsuke Kudo
Makoto Sasaki
Ken Sakushima
Ichiro Yabe
Hidenao Sasaki
Satoshi Terae
Mitsuhiro Nakanishi
Hiroki Shirato
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Neuroradiology / Issue 6/2013
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-013-1171-8

Other articles of this Issue 6/2013

Neuroradiology 6/2013 Go to the issue